A technical audit was conducted for genotyping assays and hemoglobin diagnostics to ensure accuracy and enhance diagnostic capabilities

The Department incorporated a fully automatic sectioning device. This innovation helps reduce the backlog of samples, alleviates ergonomic strain on technicians, and allows them to focus on specialized tissue types.

To improve operational efficiency and service delivery, the Department initiated the formation of horizontal working groups. These groups focused on harmonizing services, strengthening quality management, integrating the Laboratory Information Management Systems (LIMS) with other management tools, and advancing digitalization and automation.

The Department launched Phadia systems for total and specific IgE, and Tryptase testing. These activities are carried out as a lab-to-lab collaboration with the Centre Hospitalier de Luxembourg (CHL), whose activities were integrated into the department.

A new staff delegation was established, aiming to represent employees and contribute to the institution’s continuous improvement.

The first automatic microtome was inaugurated, significantly modernizing the Department’s histopathological sectioning process.

The Department was reorganized into five specialized pathology units. Each unit has a designated Head of Unit to improve standardization, enhance oversight and coordination, and foster innovation.

The Department celebrated its 10th anniversary and hosted the DGRM Conference.

The institution transitioned to electronic payslips, streamlining administrative processes and reducing paper usage.

The Department undertook a comprehensive reevaluation of its equipment and initiatives. This effort focused on resource sharing, synergistic use, and donations to create space for teamwork and enhance inter-service collaboration.

Mass spectrometry for steroids and catecholamines was launched, replacing radio-immunoassays and HPLC, and improving analytical performance.

Designated as the National Influenza Center by the World Health Organization (WHO), the Department prepared to participate in the meeting for new directors in Geneva. The department has focused on upgrading testing methods, enhancing report visualization, and strengthening national and international collaboration.

The institution launched its official Instagram account to enhance its digital presence.

A workplace restructuring took place, including the reallocation and expansion of the sample reception and registration areas. The macroscopy laboratory was also expanded, reaching a capacity of 10 positions for the macroscopic study of biopsies and surgical specimens.

The institution organized an Open Doors Day, welcoming the public to discover its activities and facilities.

The complete migration of the building’s telephony system was successfully completed, modernizing communications infrastructure.

The Department achieved accreditation in accordance with ISO 15189:2022, affirming its commitment to quality and competence in medical testing.

Internal and external documentation for pre-analytical processes was implemented as part of the department’s efforts towards accreditation.

The LNS Activity Committee was officially launched to promote employee engagement through various initiatives.

The LNS was named a finalist for the Luxembourg Quality and Excellence Award in recognition of its continuous improvement efforts, supported by its VELONA software.

The Health Directorate requested the extension of the newborn screening program to include 13 new diseases in 2025 and 2026.

The Department underwent an external OLAS audit and achieved accreditation at the departmental level and in two international standards (ISO references).

The LNS whistleblowing platform was launched, providing a secure and confidential channel for reporting concerns.

The Department received commendatory feedback during the PHEPA evaluation conducted by the ECDC, particularly in relation to laboratory preparedness and capacity.